Lastest news posted on the gmed site:
FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9933
dwmoskowitz@genomed.com
ST. LOUIS—March 6, 2009—GenoMed® (OTC Pink Sheets GMED.PK) announced today that it will be offering free medical consultations over the Internet.
Patients can reach GenoMed by entering the Skype ID of the company's CEO and Chief Medical Officer, David W. Moskowitz MD, MA(Oxon), FACP. His Skype ID is: dwmoskowitz.
During periods of light calling, GenoMed will be able to offer real-time video consultations via Skype.
Said Dr. Moskowitz, "Now that we're in a global recession, and 50 million Americans have no health insurance, it's time for us to help each other. Beginning immediately, GenoMed will be offering free medical consultations, especially for chronic diseases."
Dr. Moskowitz continued by saying, "Just as a heads-up. Our next goal is to find an insurance company somewhere in the world that's actually interested in having patients live longer, healthier lives outside of the hospital. No health insurance company wants to prevent disease--I've asked practically all of them over the past 7 years. Reinsurance companies are just as hopeless. But a catastrophic hospitalization company, or perhaps a life insurance company, might want to."
Dr. Moskowitz ended by saying, "Now we've got two of the three pieces we need for the nation's 50 million uninsured: cheap drugs which are already being offered by the big pharmacy chains, and Next Generation Disease Management for Baby Boomers, courtesy of GenoMed. Catastrophic hospitalization is the crucial third piece. When we have all three, we'll be able to avoid bankruptcy by healthcare."
About GenoMed
GenoMed published how to prevent 90% of kidney failure, and how to retard the progression of emphysema (COPD) in 2002. The company's "recipes" are the subject of pending patents, good in the US. GenoMed is now marketing its Next Generation Disease Management service globally to patients with diabetes, high blood pressure, or emphysema (COPD). Please contact GenoMed at www.genomed.com or www.thelatestmedicaltreatment.com, or call Dr. Moskowitz directly on Skype (ID = dwmoskowitz).
Safe Harbor Statement
This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.'s (the Company's) finances and treatments. The words or phrases "ought to," "should," "could," "may," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors, and the possibility of our not being able to field all the calls we receive. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
